Tag: pharmacovigilance outsourcing market outlook

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Pharmacovigilance Outsourcing Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?#_x000D_

The pharmacovigilance outsourcing market has experienced substantial growth in recent years. It is anticipated to expand from $7.24 billion in 2025 to $8.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. This historical increase can be ascribed to a rising number of new drug approvals, heightened pharmacovigilance awareness within pharmaceutical companies, a deficit of internal PV expertise, increased regulatory oversight, and the broadening scope of global clinical trials._x000D_

_x000D_

The pharmacovigilance outsourcing market is projected for significant expansion over the coming years, with its size anticipated to reach $16.09 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This projected growth during the forecast period is driven by several factors, including the integration of AI and data analytics into PV processes, increased reliance on outsourcing to CRO and BPO providers, the widespread adoption of cloud-based pharmacovigilance platforms, the broadening of global safety reporting requirements, and increased investment in IT infrastructure and technological support. Key trends observed during this period encompass a rising uptake of outsourced pharmacovigilance services by pharmaceutical companies, stricter regulatory compliance and reporting standards, increased automation in adverse drug reaction (ADR) capture and case processing, the development of knowledge management and data integration solutions, and a heightened emphasis on risk management and quality assurance services._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=49317354&type=smp&name=Pharmacovigilance%20Outsourcing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmacovigilance Outsourcing Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_

The expansion in clinical trial volumes is anticipated to drive forward the pharmacovigilance outsourcing market. These trials represent research investigations designed to assess the safety, effectiveness, and potential adverse reactions of new therapies, medications, or medical instruments. The increase in clinical trials stems from various factors, such as a heightened emphasis on individualized medicine, a greater prevalence of chronic illnesses, supportive regulations, and the global spread of research activities. By employing specialized knowledge and capabilities, pharmacovigilance outsourcing in clinical trials improves drug safety surveillance, ensuring adherence to regulatory standards and boosting operational effectiveness. As an illustration, in December 2024, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, showed that the number of industry clinical trials started in the UK rose to 426 in 2023, up from 411 in 2022. Consequently, the growing frequency of clinical trials is propelling the expansion of the pharmacovigilance outsourcing market._x000D_

_x000D_

#Pharmacovigilance Outsourcing Market Segment Analysis And Revenue Potential#_x000D_

The pharmacovigilance outsourcing market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture_x000D_

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing_x000D_

3) By End User: Pharmaceutical Industry, Research Organization, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software _x000D_

2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services _x000D_

3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services _x000D_

4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing _x000D_

5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services _x000D_

6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services _x000D_

7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms _x000D_

8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support _x000D_

_x000D_

#Pharmacovigilance Outsourcing Market Growth Trends: What’s Shaping The Future Outlook?_x000D_

Leading companies active in the pharmacovigilance outsourcing market are prioritizing the development of innovative solutions, such as cloud-based data lake platforms, to streamline pharmacovigilance case processing and safety data management procedures, thereby enhancing clinical research registries and ensuring adherence to regulatory mandates. A cloud-based data lake platform functions as a centralized repository capable of storing and managing vast quantities of raw data in its original format until it is required. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, introduced CorEvidence, specifically designed to augment clinical research registries. This platform aims to simplify pharmacovigilance case processing by integrating multiple data sources and optimizing the coding, classification, and reporting of adverse events. Its significance lies in offering scalable, compliant, and auditable safety management, which improves CorEvitas clinical research registries and supports long-term post-authorization safety studies across a variety of therapeutic areas._x000D_

_x000D_

#Pharmacovigilance Outsourcing Market Key Players Shaping Industry Direction#_x000D_

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas _x000D_

_x000D_

#View The Full Pharmacovigilance Outsourcing Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmacovigilance Outsourcing Market Geographic Spread And Regional Opportunities#_x000D_

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Pharmacovigilance Outsourcing Market Forecast Highlighting Growth From $8.51 Billion To $16.08 Billion

In recent years, the pharmacovigilance outsourcing market has seen substantial growth. Valued at $7.24 billion in 2025, it is projected to expand to $8.51 billion by 2026, delivering a compound annual growth rate (CAGR) of 17.6%. This historic momentum has been driven by several key factors, including a higher volume of new drug approvals, a growing recognition of pharmacovigilance’s importance among pharmaceutical firms, a shortage of internal pharmacovigilance expertise, tighter regulatory oversight, and the broadening scope of clinical trial activities worldwide.

The pharmacovigilance outsourcing market is anticipated to experience robust expansion over the coming years. By 2030, it is projected to reach a value of $16.09 billion, advancing at a compound annual growth rate (CAGR) of 17.2%. This upward trajectory in the forecast period can be linked to several factors, including the incorporation of artificial intelligence and data analytics into pharmacovigilance processes, heightened reliance on contract research organizations (CROs) and business process outsourcing (BPO) firms, the growing use of cloud-based platforms for safety monitoring, broader global mandates for safety reporting, and increased funding for IT infrastructure and technological tools. Key developments shaping this period involve a stronger trend toward pharma companies adopting outsourced safety services, stricter regulatory demands and evolving reporting benchmarks, greater automation in detecting and processing adverse drug reactions, improved integration of knowledge management and data solutions, along with a growing emphasis on risk mitigation and quality assurance initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmacovigilance Outsourcing Market Opportunity Drivers: What Is Creating New Revenue Potential?

An expanding volume of clinical studies is anticipated to drive future growth in the pharmacovigilance outsourcing market. These studies, which assess new drugs, treatments, or medical devices for their safety, effectiveness, and possible adverse effects, are becoming more prevalent due to factors such as an intensified emphasis on precision medicine, a growing prevalence of chronic conditions, supportive regulatory frameworks, and the worldwide expansion of research activities. By utilizing specialized expertise and resources within clinical trials, pharmacovigilance outsourcing strengthens drug safety monitoring, facilitates adherence to regulatory standards, and boosts operational efficiency. As an illustration, data from December 2024 released by the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade organization, indicates that the number of industry-led clinical trials launched in the United Kingdom rose to 426 in 2023, compared to 411 in 2022. Consequently, this upward trend in clinical trial numbers is fueling the expansion of the pharmacovigilance outsourcing market.

Pharmacovigilance Outsourcing Market Categorization By Product Type And Application

The pharmacovigilance outsourcing market covered in this report is segmented –

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Other End Users

Subsegments:

1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software

2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services

3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services

4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing

5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services

6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services

7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms

8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

Pharmacovigilance Outsourcing Market Innovation Trends Driving Future Development

Key players within the pharmacovigilance outsourcing market are prioritizing the development of cutting-edge tools like cloud-based data lake platforms to improve case processing and safety data management, with the aim of advancing clinical research registries and satisfying regulatory standards. A cloud-based data lake platform functions as a centralized storage system that enables the handling of substantial volumes of raw data while preserving its original format until necessary. In December 2023, Thermo Fisher Scientific Inc., a biotechnology and laboratory equipment provider headquartered in the United States, introduced CorEvidence with the goal of boosting clinical research registries. This solution is intended to facilitate pharmacovigilance case processing by integrating diverse data sources and enhancing the coding, classification, and reporting of adverse events. Its importance is derived from its capacity to deliver scalable, compliant, and auditable safety management, strengthen CorEvitas clinical research registries, and sustain long-term post-authorization safety studies across multiple therapeutic fields.

Pharmacovigilance Outsourcing Market Company Landscape And Strategic Competition

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Access The Complete Pharmacovigilance Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmacovigilance Outsourcing Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Pharmacovigilance Outsourcing Market Between 2026 And 2030?

The pharmacovigilance outsourcing market’s size has seen substantial growth over recent years. It is anticipated to increase from $7.24 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. Historically, this expansion can be ascribed to a rising number of new drug approvals, increased pharmacovigilance awareness among pharmaceutical companies, a deficit of internal PV expertise, enhanced regulatory scrutiny, and the broadening of global clinical trials.

The pharmacovigilance outsourcing market is projected for significant expansion in the coming years, with its valuation anticipated to reach $16.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.2%. This projected growth is driven by several factors, including the integration of artificial intelligence and data analytics into pharmacovigilance processes, a rise in outsourcing to Contract Research Organizations (CRO) and Business Process Outsourcing (BPO) providers, the uptake of cloud-based pharmacovigilance platforms, the broadening of global safety reporting mandates, and increased investment in IT infrastructure and technological support. Key trends anticipated during this period encompass the growing embrace of outsourced pharmacovigilance services by pharmaceutical firms, more stringent regulatory compliance needs and reporting benchmarks, an increase in the automation of adverse drug reaction (ADR) capture and case processing, the development of knowledge management and data integration tools, and a sharpened emphasis on risk management and quality assurance services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

Which Core Factors Are Supporting The Expansion Of The Pharmacovigilance Outsourcing Market?

An increasing volume of clinical trials is anticipated to boost the expansion of the pharmacovigilance outsourcing market in the future. These trials are research endeavors undertaken to assess the safety, effectiveness, and possible adverse reactions of novel treatments, medications, or medical devices. Several factors contribute to the rise in clinical trials, such as an increased emphasis on precision medicine, the growing prevalence of chronic illnesses, support from regulators, and the worldwide nature of research. Within clinical trials, pharmacovigilance outsourcing strengthens drug safety oversight by utilizing specialized knowledge and resources, ensuring adherence to regulatory mandates and enhancing operational effectiveness. For instance, in December 2024, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, indicated that the number of industry clinical trials launched in the UK climbed to 426 in 2023, up from 411 in 2022. Consequently, the escalating count of clinical trials is propelling the growth of the pharmacovigilance outsourcing market.

What Segment Categories Are Evaluated In The Pharmacovigilance Outsourcing Market Study?

The pharmacovigilance outsourcing market covered in this report is segmented –

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Other End Users

Subsegments:

1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software

2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services

3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services

4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing

5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services

6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services

7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms

8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

What Trends Are Influencing The Pharmacovigilance Outsourcing Market Outlook?

Major entities within the pharmacovigilance outsourcing sector are prioritizing the creation of advanced solutions, like cloud-based data lake platforms, to refine pharmacovigilance case processing and safety data management. This effort aims to enhance clinical research registries and guarantee adherence to regulatory standards. A cloud-based data lake platform serves as a central repository designed for storing and overseeing vast quantities of raw data in its native form until needed. As an illustration, in December 2023, Thermo Fisher Scientific Inc., a biotechnology and laboratory equipment company based in the US, introduced CorEvidence, which is designed to improve clinical research registries. This solution is engineered to simplify pharmacovigilance case processing by integrating multiple data sources and optimizing the coding, classification, and reporting of adverse events. Its value stems from offering scalable, compliant, and auditable safety management, thereby strengthening CorEvitas clinical research registries and supporting extended post-authorization safety studies across numerous therapeutic areas.

Who Are The Companies Shaping The Pharmacovigilance Outsourcing Market Landscape?

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Access The Complete Pharmacovigilance Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

Which Region Has The Strongest Presence In The Pharmacovigilance Outsourcing Market?

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmacovigilance Outsourcing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance Outsourcing Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Veterinary Pharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Pharmaceutical Sterility Testings Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Pharmacovigilance Outsourcing Market Over The 2026–2030 Period?

The pharmacovigilance outsourcing market has experienced rapid expansion in recent years. It is projected to grow from $7.24 billion in 2025 to $8.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. The market’s historical growth can be attributed to an escalating number of new drug approvals, increased pharmacovigilance awareness among pharma companies, a deficiency in in-house pv expertise, intensifying regulatory scrutiny, and the broader expansion of global clinical trials.

The pharmacovigilance outsourcing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $16.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. Key drivers for this growth during the forecast period include the incorporation of AI and data analytics into PV processes, a rise in outsourcing to contract research organizations (CROs) and business process outsourcing (BPO) providers, the embrace of cloud-based pharmacovigilance platforms, the widening scope of global safety reporting mandates, and increased investment in IT infrastructure and technological assistance. Significant trends predicted for the forecast period encompass a greater uptake of outsourced pharmacovigilance services by pharmaceutical companies, stricter regulatory compliance demands and reporting benchmarks, an increase in the automation of adverse drug reaction (ADR) capture and case handling, the development of knowledge management and data integration tools, and a heightened emphasis on risk management and quality assurance offerings.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

Which Key Factors Are Driving The Pharmacovigilance Outsourcing Market Growth?

The increasing volume of clinical trials is anticipated to boost the expansion of the pharmacovigilance outsourcing market. These trials are investigative studies performed to assess the safety, effectiveness, and possible adverse effects of novel therapies, medications, or medical instruments. The escalation in clinical trials stems from various factors, such as an increased emphasis on personalized medicine, the growing prevalence of chronic illnesses, favorable regulatory environments, and the global spread of research activities. Outsourcing pharmacovigilance during clinical trials improves drug safety oversight by utilizing specific knowledge and assets to guarantee adherence to regulatory mandates and enhance operational effectiveness. As an illustration, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, revealed that the number of industry clinical trials initiated in the UK rose to 426 in 2023, an increase from 411 in 2022. This particular finding was reported in December 2024. Consequently, the increased volume of clinical trials is fueling the expansion of the pharmacovigilance outsourcing market.

How Is The Pharmacovigilance Outsourcing Market Segmented Across Different Segment Categories?

The pharmacovigilance outsourcing market covered in this report is segmented –

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Other End Users

Subsegments:

1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software

2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services

3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services

4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing

5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services

6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services

7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms

8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

Which Trends Are Contributing To Changes In The Pharmacovigilance Outsourcing Market?

Major companies within the pharmacovigilance outsourcing market are concentrating their efforts on creating advanced solutions, such as cloud-based data lake platforms. These innovations aim to optimize the handling of pharmacovigilance cases and the management of safety data, thereby improving clinical research registries and ensuring adherence to regulatory standards. A cloud-based data lake platform functions as a central storage facility, capable of holding and organizing vast quantities of raw data in its original form until it is needed. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, introduced CorEvidence. This platform was specifically designed to enhance clinical research registries and simplify pharmacovigilance case processing by integrating various data sources and refining the coding, classification, and reporting of adverse events. Its importance stems from its ability to offer scalable, compliant, and auditable safety management, bolstering CorEvitas clinical research registries, and aiding extended post-authorization safety studies across diverse therapeutic domains.

Which Organizations Play A Role In The Pharmacovigilance Outsourcing Market Landscape?

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Get The Full Pharmacovigilance Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

Which Region Is The Leading Market For The Pharmacovigilance Outsourcing Market?

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmacovigilance Outsourcing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

Browse Through More Reports Similar to the Global Pharmacovigilance Outsourcing Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Veterinary Pharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Pharmaceutical Sterility Testings Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Pharmacovigilance Outsourcing Market Expected To Change Between 2026 And 2030?

The pharmacovigilance outsourcing market has experienced significant expansion in recent years. It is projected to grow from $7.24 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. The historical surge in this market can be attributed to an escalating volume of new drug approvals, heightened pharmacovigilance awareness among pharmaceutical firms, a shortage of in-house PV expertise, intensified regulatory oversight, and the broadening scope of global clinical trials.

The pharmacovigilance outsourcing market size is projected to experience substantial growth in the upcoming years. It is expected to expand to $16.09 billion by 2030, showing a compound annual growth rate (CAGR) of 17.2%. This projected growth can be attributed to several factors, including the integration of AI and data analytics into PV processes, an increase in outsourcing to CRO and BPO providers, the adoption of cloud-based pharmacovigilance platforms, the expansion of global safety reporting requirements, and growing investment in IT infrastructure and technology support. Significant trends during this forecast period involve the increasing uptake of outsourced pharmacovigilance services by pharmaceutical companies, evolving regulatory compliance requirements and reporting standards, advancements in the automation of ADR capture and case processing, the expansion of knowledge management and data integration solutions, and an enhanced focus on risk management and quality assurance services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

Which Economic Or Industry Drivers Are Impacting The Pharmacovigilance Outsourcing Market?

A future surge in the pharmacovigilance outsourcing market is anticipated, driven by an increasing volume of clinical trials. These studies involve investigations into new treatments, medications, or medical devices to assess their safety, effectiveness, and any adverse reactions. The escalation in clinical trials stems from multiple factors, such as a heightened emphasis on precision medicine, the growing prevalence of chronic illnesses, supportive regulations, and the expansion of research globally. Utilizing pharmacovigilance outsourcing within clinical trials improves drug safety oversight by employing specialized knowledge and assets, thereby ensuring adherence to regulatory standards and boosting operational efficiency. For example, data from December 2024, provided by the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, showed that industry clinical trials started in the UK rose to 426 in 2023, up from 411 in 2022. Consequently, the expanding volume of clinical trials is a key impetus for the growth of the pharmacovigilance outsourcing market.

How Is The Pharmacovigilance Outsourcing Market Structured Across Different Segments?

The pharmacovigilance outsourcing market covered in this report is segmented –

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Other End Users

Subsegments:

1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software

2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services

3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services

4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing

5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services

6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services

7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms

8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

Which Trends Are Shaping The Future Of The Pharmacovigilance Outsourcing Market?

Major companies in the pharmacovigilance outsourcing market are concentrating on developing innovative solutions, such as cloud-based data lake platforms, to optimize pharmacovigilance case processing and safety data management. This effort aims to enhance clinical research registries and ensure adherence to regulatory requirements. A cloud-based data lake platform functions as a central repository, enabling the storage and management of vast quantities of raw data in its native format until needed. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, launched CorEvidence, specifically designed to improve clinical research registries. It is built to streamline pharmacovigilance case processing by managing multiple data sources and refining the coding, classification, and reporting of adverse events. The significance of CorEvidence lies in its ability to provide scalable, compliant, and auditable safety management, thereby enhancing CorEvitas clinical research registries and supporting long-term post-authorization safety studies across various therapeutic areas.

Which Major Players Dominate The Pharmacovigilance Outsourcing Market?

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Read the full pharmacovigilance outsourcing market report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

What Are The Top-Performing Regions Within The Pharmacovigilance Outsourcing Market?

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmacovigilance Outsourcing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19651&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance Outsourcing Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Veterinary Pharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Pharmaceutical Sterility Testings Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmacovigilance outsourcing market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Pharmacovigilance Outsourcing Market in 2026, and what figure is it projected to hit by 2030?

The pharmacovigilance outsourcing market has seen substantial growth in its size over recent years. It is projected to expand from $7.24 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. The historical growth of this market can be ascribed to factors such as an increasing volume of new drug approvals, enhanced pharmacovigilance awareness among pharmaceutical companies, a shortage of in-house PV expertise, escalating regulatory scrutiny, and the broadening of global clinical trials.

The pharmacovigilance outsourcing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $16.09 billion by the year 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This anticipated growth during the forecast period is fueled by several factors, including the integration of AI and data analytics into PV processes, a rise in outsourcing to CRO and BPO providers, the widespread adoption of cloud-based pharmacovigilance platforms, the broadening of global safety reporting requirements, and increased investment in IT infrastructure and technological support. Key trends expected within this period involve the increasing uptake of outsourced pharmacovigilance services by pharmaceutical companies, the escalating demands for regulatory compliance and reporting standards, advancements in the automation of ADR capture and case processing, the development of knowledge management and data integration solutions, and a heightened emphasis on risk management and quality assurance services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

Which Drivers Are Affecting Market Participation In The Pharmacovigilance Outsourcing Market?

The increasing volume of clinical trials is projected to fuel expansion within the pharmacovigilance outsourcing market. These trials involve research investigations designed to assess the safety, effectiveness, and potential adverse effects of new medical treatments, drugs, or devices. This increase in clinical trials stems from various factors, including a heightened focus on precision medicine, the growing prevalence of chronic illnesses, regulatory encouragement, and the worldwide expansion of research activities. Utilizing pharmacovigilance outsourcing in clinical trials significantly improves drug safety oversight by harnessing specialized knowledge and resources, thereby ensuring adherence to regulatory standards and boosting operational effectiveness. A notable example comes from December 2024, where the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade organization, reported that the number of industry-initiated clinical trials in the UK rose to 426 in 2023, up from 411 in 2022. Consequently, the growing frequency of clinical trials is acting as a primary catalyst for the growth of the pharmacovigilance outsourcing market.

What Segment Classifications Make Up The Pharmacovigilance Outsourcing Market?

The pharmacovigilance outsourcing market covered in this report is segmented –

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Other End Users

Subsegments:

1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software

2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services

3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services

4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing

5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services

6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services

7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms

8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

What Trends Are Projected To Support The Growth Of The Pharmacovigilance Outsourcing Market?

Major companies within the pharmacovigilance outsourcing market are concentrating on creating innovative solutions, such as a cloud-based data lake platform. Their goal is to enhance pharmacovigilance case processing and safety data management, thereby improving clinical research registries and ensuring adherence to regulatory standards. A cloud-based data lake platform serves as a central repository, allowing the storage and management of large volumes of raw data in its original format until needed. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, introduced CorEvidence, specifically designed to enhance clinical research registries. This solution aims to streamline pharmacovigilance case processing by integrating multiple data sources and optimizing the coding, classification, and reporting of adverse events. Its importance stems from offering scalable, compliant, and auditable safety management, enhancing CorEvitas clinical research registries, and supporting long-term post-authorization safety studies across various therapeutic areas.

Which Key Players Are Driving Competition In The Pharmacovigilance Outsourcing Market?

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

Which Region Is Projected To Lead The Pharmacovigilance Outsourcing Market During The Forecast Period?

North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmacovigilance Outsourcing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19651&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance Outsourcing Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Veterinary Pharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Pharmaceutical Sterility Testings Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the pharmacovigilance outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Pharmacovigilance Outsourcing Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

Recent years have seen a swift expansion in the size of the pharmacovigilance outsourcing market. The market, which was valued at $6.16 billion in 2024, is projected to grow to $7.24 billion in 2025, representing a compound annual growth rate (CAGR) of 17.6%. The historical growth of the market is as a result of increased drug development initiatives, stringent regulatory norms, a growing number of adverse drug reaction incidents, escalating concerns over patient safety, and a higher trend of outsourcing from small and medium-sized firms._x000D_

_x000D_

The market size of pharmacovigilance outsourcing is predicted to undergo swift expansion in the coming years, reaching $13.73 billion in 2029 with a compound annual growth rate (CAGR) of 17.3%. The predicted upswing during the forecast period is contributed by factors such as the proliferation of biologics and biosimilars, increasing attention given to personalized medicine, rising need for real-world evidence, escalating drug safety profile complexities, and the heightened focus on patient-centric care. The forecast period is also characterized by trending developments such as amplifying utilization of big data analytics, a surge in partnerships and collaborations, the embracing of cloud-based pharmacovigilance strategies, incorporation of pharmacovigilance with digital health systems, and the emergence of specialized pharmacovigilance services tailored for gene therapies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of the Pharmacovigilance Outsourcing Market?#_x000D_

The upswing in clinical trials is projected to be a key driver in stimulating the expansion of the pharmacovigilance outsourcing market. Clinical trials, studies performed to assess the safety, efficiency, and possibility of side effects of novel treatments, medications, or medical equipment, are experiencing a surge due to various factors. The increasing emphasis on precision medicine, the growing prevalence of chronic ailments, regulatory support, and the internationalization of research all contribute significantly to this trend. Pharmacovigilance outsourcing offers an enhancement in drug safety monitoring during clinical trials by harnessing specialized skills and resources to maintain regulatory compliance and boost efficiency. An example of this is the slight 4.3% increase in the total number of industry-sponsored clinical trials initiated in the UK, as noted by the UK-based trade association, the Association of the British Pharmaceutical Industry, in November 2023. This escalated from 394 trials in 2021 to 411 in 2022. As such, the escalating number of clinical trials is spurring on the growth of the pharmacovigilance outsourcing market._x000D_

_x000D_

#What Segment Types Define the Pharmacovigilance Outsourcing Market Structure?#_x000D_

The pharmacovigilance outsourcingmarket covered in this report is segmented –_x000D_

_x000D_

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture_x000D_

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing_x000D_

3) By End User: Pharmaceutical Industry, Research Organization, Others End Users_x000D_

_x000D_

Subsegments:_x000D_

1) Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software_x000D_

2) Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services_x000D_

3) Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services_x000D_

4) Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing_x000D_

5) Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services_x000D_

6) Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services_x000D_

7) Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms_x000D_

8) Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=19651&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Pharmacovigilance Outsourcing Market?#_x000D_

North America was the largest region in the pharmacovigilance outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering the Pharmacovigilance Outsourcing Market Direction?#_x000D_

Major firms in the pharmacovigilance outsourcing market are prioritizing the design of innovative solutions, such as a cloud-based data lake platform. These platforms aim to streamline pharmacovigilance case handling and improve the management of safety data, thereby strengthening clinical research registries and ensuring adherence to regulatory standards. A cloud-based data lake platform is a centralized storage system that can hold and manage vast quantities of raw data in their original format until required. For instance, Thermo Fisher Scientific Inc., a biotechnology and lab equipment company from the U.S., launched CorEvidence in December 2023. This is designed to boost clinical research registries and simplify pharmacovigilance case management by effectively handling multiple data sources, and enhancing the coding, classification, and reporting of adverse events. This tool provides scalable, compliant, auditable safety management which enhances CorEvitas clinical research registries and aids in long-term post-authorization safety studies across various therapeutic fields._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report_x000D_

_x000D_

#What Is the Definition of the Pharmacovigilance Outsourcing Market?#_x000D_

Pharmacovigilance outsourcing refers to the practice of hiring external service providers to manage and conduct pharmacovigilance activities on behalf of pharmaceutical companies. These activities include detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19651_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Pharmacovigilance Outsourcing Market Over the Coming Decade?

In recent times, the pharmacovigilance outsourcing market has seen a swift expansion. It is set to progress from $6.16 billion in 2024 to $7.24 billion in 2025, showcasing a compound annual growth rate (CAGR) of 17.6%. The historic expansion can be linked to an upsurge in drug development undertakings, stringent regulatory necessities, a heightened occurrence of detrimental drug reactions, growing concerns about patient safety, and a rise in outsourcing by small to medium-sized firms.

The section of the industry that outsources pharmacovigilance is likely to experience a swift growth spurt in the coming years, growing to $13.73 billion in 2029, with a compound annual growth rate (CAGR) of 17.3%. The predicted growth during forecasted time frame can be linked to the rise of biologics and biosimilars, the enhanced focus on custom-made medicine, the increased need for evidence derived from real-world scenarios, the rising intricacy of drug safety databases, as well as the expanded focus on care centered around the patient. Key trends anticipated during this forecast period consist of the heightened utilization of large scale data analytics, more partnerships and collaborations, the application of cloud-based pharmacovigilance solutions, the amalgamation of pharmacovigilance with digital healthcare platforms and the advancement of specific pharmacovigilance services for gene therapies.

What Major Innovations Are Driving the Accelerated Growth of the Pharmacovigilance Outsourcing Market?

The growth of the pharmacovigilance outsourcing market is predicted to surge due to the increasing number of clinical trials. These trials are research studies that test the safety, effectiveness, and possible side effects of new treatments or medical devices. An expansion in the number of clinical trials can be attributed to various factors, such as a heightened emphasis on precision medicine, the growing prevalence of chronic diseases, regulatory backing, and the internationalization of research. By employing expertise and resources in clinical trials, pharmacovigilance outsourcing enhances drugs safety monitoring, ensures regulatory compliance, and bolsters efficiency. For instance, the Association of the British Pharmaceutical Industry, a trade organization based in the UK, reported in November 2023 that the total count of industry-funded clinical trials initiated in the UK rose mildly by 4.3%, from 394 trials in 2021 to 411 in 2022. Accordingly, the surge in the number of clinical trials fuels the growth of the pharmacovigilance outsourcing market.

Get Your Free Sample of the Global Pharmacovigilance Outsourcing Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

What Are the Major Players Making an Impact in the Pharmacovigilance Outsourcing Market’s Growth?

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (LabCorp), Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Global Pharma Tek, Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

Which Upcoming Trends Are Set to Influence the Pharmacovigilance Outsourcing Market’s Path Forward?

Leading firms in the pharmacovigilance outsourcing sector are looking to develop inventive solutions such as a cloud-based data lake platform to improve pharmacovigilance case handling and bolster safety data management systems. These solutions aim to upgrade clinical research registries and ensure regulatory compliance. A cloud-based data lake platform acts as a centralized storage system, making it easier to store and handle vast volumes of raw data in its original format until required. An example of this came in December 2023, when the biotechnology and lab equipment conglomerate, Thermo Fisher Scientific Inc., based in the USA, unveiled CorEvidence. This product promises to streamline pharmacovigilance case processing by successfully managing multiple sets of data and optimising the codification, categorisation, and submission of adverse events. The platform is vital as it offers scalabale, regulatory compliant, auditable safety management; improves the CorEvitas clinical research registries; and assist in long-term post-authorization safety studies across various therapeutic domains.

Get Instant Access to the Global Pharmacovigilance Outsourcing Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

Which Key Segments of the Pharmacovigilance Outsourcing Market Are Poised for Growth and Innovation?

The pharmacovigilance outsourcingmarket covered in this report is segmented –

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Others End Users

Subsegments:

1) Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software

2) Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services

3) Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services

4) Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing

5) Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services

6) Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services

7) Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms

8) Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support

What Regions Are Steering Growth in the Pharmacovigilance Outsourcing Sector?

North America was the largest region in the pharmacovigilance outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Pharmacovigilance Outsourcing Market and Its Key Components?

Pharmacovigilance outsourcing refers to the practice of hiring external service providers to manage and conduct pharmacovigilance activities on behalf of pharmaceutical companies. These activities include detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems.

Browse Through More Similar Reports By The Business Research Company:

Pharmaceutical Filtration Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-filtration-global-market-report

Pharmaceutical Glass Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-glass-packaging-global-market-report

Pharmaceutical Contract Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-contract-packaging-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s Year-End Sale! Get up to 30% off on comprehensive market research reports—limited time only!

At What Rate is the Pharmacovigilance Outsourcing Market Predicted to Expand Between 2024 and 2033?

• The pharmacovigilance outsourcing market size has grown rapidly in recent years. It will grow from $5.25 billion in 2023 to $6.16 billion in 2024 at a compound annual growth rate (CAGR) of 17.3%.

• The pharmacovigilance outsourcing market size is expected to see rapid growth in the next few years. It will grow to $11.71 billion in 2028 at a compound annual growth rate (CAGR) of 17.4%.

Get A Free Sample On The Global Pharmacovigilance Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp

What Factors Are Encouraging Growth in the pharmacovigilance outsourcing Market?

• The rising number of clinical trials is expected to propel the growth of the pharmacovigilance outsourcing market going forward.

• Clinical trials are research studies conducted to evaluate the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices.

• Clinical trials are rising due to several reasons, including the growing focus on precision medicine, the rising incidence of chronic diseases, regulatory support, and the globalization of research.

Which Segments Are Crucial in the Pharmacovigilance Outsourcing Market?

1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture

2) By Service Provider: Contract Research Organization, Business Processing Outsourcing

3) By End User: Pharmaceutical Industry, Research Organization, Others End Users

Purchase The Global Pharmacovigilance Outsourcing Market Report Directly And Get A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report

Which Market Leaders Are Behind the Growth of the Pharmacovigilance Outsourcing Market?

Leading companies driving the global pharmacovigilance outsourcing market include:

• ACCENTURE PLC

• International Business Machines Corporation (IBM)

• Tata Consultancy Services

• Capgemini SE

• Cognizant Technology Solutions Corporation

What Trends Are Driving Change in the #At What Rate is the Pharmacovigilance Outsourcing Market Predicted to Expand Between 2024 and 2033?# Market?

• Major companies operating in the pharmacovigilance outsourcing market are focusing on developing innovative solutions, such as a cloud-based data lake platform, to optimize pharmacovigilance case processing and safety data management processes for enhancing clinical research registries and ensuring compliance with regulatory requirements.

• A cloud-based data lake platform is a centralized repository that allows you to store and manage large amounts of raw data in its native format until it’s needed.

Which Geographic Locations Are Critical to the Growth of the Pharmacovigilance Outsourcing Market?

North America was the largest region in the pharmacovigilance outsourcing market in 2023

The Table Of Content For The Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Include

1. Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Executive Summary

2. Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Segments

3. Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Size And Template Market Growth Rate

4. Key Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Trends

5. Major Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Drivers

……

25. Key Mergers And Acquisitions In The Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market

26. Top Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Companies

27. Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market Opportunities And Strategies

28. Evaluating the Pharmacovigilance Outsourcing Market’s Growth Prospects from 2024 to 2033 Market, Conclusions And Recommendations

29. Appendix

Browse Through More Similar Reports By The Business Research Company:

Pharmaceutical Drug Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Pharmaceutical Sterility Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: